Projects
Structural characterisation of the insulin-like growth factor (IGF) binding proteins and IGF receptors, their interactions with other physiological molecules and alterations in metabolic disorders
| Code |
Science |
Field |
| B190 |
Biomedical sciences |
Clinical chemistry |
| P004 |
Natural sciences and mathematics |
Biochemistry, Metabolism |
| P310 |
Natural sciences and mathematics |
Proteins, enzymology |
| P370 |
Natural sciences and mathematics |
Macromolecular chemistry |
IGFBP, IGF-R, isoforms, complexes, metabolism
Organisations (1)
, Researchers (1)
0134 University of Belgrade, Institute for the Application of Nuclear Energy
| no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
| 1. |
08792 |
Olgica Nedić |
Biochemistry, Metabolism |
Head |
2011 - 2019 |
26 |
Abstract
The main objective of the project is to study the structure of the insulin-like growth factor (IGF) binding proteins (IGFBPs) and receptors (IGF-Rs) and the formation of complexes with other molecules. The structure of IGFBPs and IGF-Rs is modified post-translationally by proteolysis, glycosylation, phosphorylation and polymerisation, and the factors that may have an influence on these processes are nutrition, physical activity, metabolic and other disorders. IGFBP-1 concentration is inversely correlated with insulin and the objective is to examine whether metabolic disturbances (diabetes, hypoglycaemia, gastrointestinal tumour) affect IGFBP-1 phosphorylation pattern. AS IGFBP-1 intereacts with alpha2 macroglobulin, the intention is to investigate the influence of disorders on this association. IGFBP-3 is glycoprotein and appears in several glycoforms. Different glycoforms having altered affinity for IGFs may appear due to metabolic disturbances, which we intend to study. IGFBP-3 binds to transferrin (Tf) and we intend to analyse samples with different ratio IGFBP-3 : Tf and different Tf saturation. The plan is to study the type and sugar content of glycans attached to IGF-Rs and their influence on ligand binding. Placenta from healthy and diabetic women will be used as a source of receptors. The binding of IGFs to receptors triggers pathways which may initiate tumour growth, thus, we will analyse glycans of IGF-Rs isolated from gastrointestinal tumours.